Page last updated: 2024-12-05

isophorone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Isophorone is a colorless liquid with a pungent odor. It is a cyclic ketone, specifically a 3,5,5-trimethylcyclohex-2-en-1-one. Isophorone is used as a solvent, a precursor to other chemicals, and in the production of polymers. It is synthesized through a process called the aldol condensation of acetone. Isophorone exhibits various effects, including being a potential irritant to the skin, eyes, and respiratory system. It can also be toxic to aquatic life. Isophorone is studied due to its potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. Research focuses on understanding its reactivity, exploring new synthetic pathways, and evaluating its environmental impact.'

isophorone : A cyclic ketone, the structure of which is that of cyclohex-2-en-1-one substituted by methyl groups at positions 3, 5 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6544
CHEMBL ID1882894
CHEBI ID34800
SCHEMBL ID22522
MeSH IDM0047822

Synonyms (113)

Synonym
BIDD:ER0627
.alpha.-isophoron
wln: l6v butj c1 d1 d1
2-cyclohexen-1-one,5,5-trimethyl-
izoforon
isoacetophorone
3,5-trimethyl-2-cyclohexen-1-one
78-59-1
.alpha.-isophorone
isophorone
isoforon
3,5-trimethyl-2-cyclohexen-1-on (german, dutch)
nsc4881 ,
3,5-trimethyl-2-cyclohexenone
nci-c55618
nsc-4881
isophoron
1,3-trimethyl-3-cyclohexene-5-one
3,5-trimetil-2-cicloesen-1-one
isoforone
3,5-trimethyl-2-cyclohexene-1-one
2-cyclohexen-1-one, 3,5,5-trimethyl-
alpha-isophorone
3,5,5-trimethyl-2-cyclohexenone
3,5,5-trimethyl-2-cyclohexen-1-one
isoforone [italian]
1,5,5-trimethyl-1-cyclohexen-3-one
caswell no. 506
3,5,5-trimetil-2-cicloesen-1-one [italian]
3,5,5-trimethylcyclohex-2-en-1-one
einecs 201-126-0
epa pesticide chemical code 047401
3,5,5-trimethylcyclohexen one
3,5,5-trimethylcyclohexenone
isooctopherone
ai3-00046
3,5,5-trimethylcyclohex-2-enone
3,5,5-trimethyl-2-cyclohexen-1-on [german, dutch]
izoforon [polish]
nsc 403657
hsdb 619
ccris 1353
brn 1280721
fema no. 3553
isophorone, reag
nsc-403657
nsc403657
1,1,3-trimethyl-3-cyclohexene-5-one
inchi=1/c9h14o/c1-7-4-8(10)6-9(2,3)5-7/h4h,5-6h2,1-3h
isophorone, analytical standard
isophorone, >=97%, fg
isophorone, 97%
NCGC00164006-01
NCHEM.180-COMP3 ,
AC-10580
I0151
STK801792
AKOS000120392
A839454
NCGC00164006-03
NCGC00164006-02
3,5,5-trimethyl-cyclohex-2-en-1-one
dtxcid40759
dtxsid8020759 ,
tox21_300050
tox21_202312
NCGC00259861-01
NCGC00254115-01
cas-78-59-1
3,5,5-trimetil-2-cicloesen-1-one
unii-2br99vr6wa
4-07-00-00165 (beilstein handbook reference)
ec 201-126-0
2br99vr6wa ,
3,5,5-trimethyl-2-cyclohexen-1-on
FT-0627443
CHEBI:34800 ,
S2998
BBL027346
SCHEMBL22522
isophorone [hsdb]
isophorone [mi]
1,3,3-trimethylcylohexen-5-one
isoacetophoron
isophorone [fhfi]
1,5,5-trimethyl-3-oxocyclohexene
AKOS025243269
3,5,5-trimethylcyclohexa-2-en-1-one
3,3,5-trimethyl-cyclohex-5 -en-1-one
3,3,5-trimethyl-cyclohex-5-en-1-one
W-104274
CHEMBL1882894
3,5,5-trimethyl-2-cyclohexene-1-one
3,3,5-trimethyl-2-cyclohexen-1-one
3,5,5-trimethylcyclohexen-2-one-1
F0001-2053
mfcd00001584
isophorone, vetec(tm) reagent grade, 97%
fema 3553
a-isophorone
1,1, 3-trimethyl-3-cyclohexene-5-one
3,5, 5-trimethyl-2-cyclohexene-1-one
alpha -isophoron
alpha -isophorone
CS-0015924
Q415519
Z104477948
VS-08530
3,5,5-trimethyl-cyclohex-2-enone
D72515
3,5,5-trimethylcyclohex-2-ene-1-one
HY-Y0932
EN300-20384

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dosed male rats developed proliferative lesions of the kidney including hyperplasia, adenoma, and adenocarcinoma of the renal tubule, and epithelial hyperplasia of the renal pelvis."( Toxicology and carcinogenesis studies of isophorone in F344 rats and B6C3F1 mice.
Bucher, JR; Huff, J; Kluwe, WM, 1986
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
solventA liquid that can dissolve other substances (solutes) without any change in their chemical composition.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cyclic ketone
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency36.62150.007215.758889.3584AID1224835
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency5.04203.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency2.50310.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency55.33390.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency9.96510.000221.22318,912.5098AID1259243
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency7.05470.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency11.42410.001022.650876.6163AID1224838; AID1224839
progesterone receptorHomo sapiens (human)Potency6.28750.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency4.99440.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency4.00500.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency32.89980.001530.607315,848.9004AID1224841; AID1224848; AID1224849
pregnane X nuclear receptorHomo sapiens (human)Potency62.87530.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.88870.000229.305416,493.5996AID1259244; AID743075
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588536
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency14.21020.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency82.34690.039147.5451146.8240AID1224845
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency5.60380.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency5.60380.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (12.07)18.7374
1990's4 (6.90)18.2507
2000's14 (24.14)29.6817
2010's21 (36.21)24.3611
2020's12 (20.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.63 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index85.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other59 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]